Page last updated: 2024-09-04

eglumetad and 1-aminocyclopentane-1,3,4-tricarboxylic acid

eglumetad has been researched along with 1-aminocyclopentane-1,3,4-tricarboxylic acid in 3 studies

Compound Research Comparison

Studies
(eglumetad)
Trials
(eglumetad)
Recent Studies (post-2010)
(eglumetad)
Studies
(1-aminocyclopentane-1,3,4-tricarboxylic acid)
Trials
(1-aminocyclopentane-1,3,4-tricarboxylic acid)
Recent Studies (post-2010) (1-aminocyclopentane-1,3,4-tricarboxylic acid)
1905481707

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acher, FC; Brabet, I; Jullian, N; Pin, JP1
Acher, FC; Bertrand, HO; Bessis, AS; Pin, JP1
Acher, F; Bertrand, HO; Brabet, I; Pin, JP; Triballeau, N1

Other Studies

3 other study(ies) available for eglumetad and 1-aminocyclopentane-1,3,4-tricarboxylic acid

ArticleYear
Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
    Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9

    Topics: Animals; Binding Sites; Cell Line; CHO Cells; Cricetinae; Glutamates; Ligands; Models, Molecular; Molecular Conformation; Receptors, Metabotropic Glutamate; Structure-Activity Relationship

1999
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
    Journal of medicinal chemistry, 2002, Jul-18, Volume: 45, Issue:15

    Topics: Binding Sites; Crystallography, X-Ray; Excitatory Amino Acid Agonists; Glutamic Acid; Ligands; Models, Molecular; Receptors, Metabotropic Glutamate; Sequence Homology, Amino Acid; Structure-Activity Relationship

2002
Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.
    Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7

    Topics: Binding Sites; Databases, Factual; Drug Design; Models, Molecular; Quantitative Structure-Activity Relationship; Receptors, Metabotropic Glutamate; ROC Curve

2005